Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the effectiveness of PD-217,014 in the treatment of chronic pain following a shingles infection.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT06821607 · Chronic Low Back Pain
NCT06382272 · Mastectomy, Breast, and more
NCT07231419 · Diabetic Peripheral Neuropathic Pain
NCT07553000 · Wrist Injuries, Wrist Fracture, and more
NCT04577690 · Pain, Postoperative, Child, and more
Pfizer Investigational Site
Warrawong, New South Wales
Pfizer Investigational Site
Westmead, New South Wales
Pfizer Investigational Site
Kippa-Ring, Queensland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions